| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/05/1994 | EP0577558A2 Carbocyclic nucleosides having bicyclic rings, oligonucleotides therefrom, process for their preparation, their use and intermediates |
| 01/05/1994 | EP0577481A1 New therapeutic application of a Thyme extract and in-vitro methods for inhibiting the growth and urease activity of Helicobacter pylori |
| 01/05/1994 | EP0577243A2 Recombinant human HIV-neutralizing monoclonal antibodies for prevention and treatment of HIV infection |
| 01/05/1994 | EP0577218A1 Heterocyclyl-phenoxyalkyl-piperidinylpyridazines as antiviral agents |
| 01/05/1994 | EP0577217A1 Tetrazolyl-(phenoxy and phenoxyalkyl) piperidininylpyridazines as antiviral agents |
| 01/05/1994 | EP0576483A1 Biocidal proteins |
| 01/05/1994 | EP0576471A1 Recombinant virus vectors encoding human papillomavirus proteins |
| 01/05/1994 | EP0576439A1 Monoclonal antibody against lps core |
| 01/05/1994 | EP0576425A1 Method for inactivating enveloped viruses and sperm |
| 01/05/1994 | EP0576420A1 Novel derivative of caffeic acid, oraposide, cosmetic or pharmaceutical, particularly dermatological, composition containing it. |
| 01/05/1994 | DE4320889A1 New substance with anti-HIV activity - is extracted from Ricinus seed and Coptis root flours, useful for treating AIDS |
| 01/05/1994 | DE4222289C1 Verfahren und Mittel zur Instabilisierung von viralen Quasi-Spezies-Verteilungen unter Vermeidung von Resistenzphänomenen Method and means for instabilization of viral quasi-species distributions while avoiding phenomena of resistance |
| 01/05/1994 | CN1080292A Antivibal compounds |
| 01/05/1994 | CN1080188A Prevention of retinal injury and degeneration by specific factors |
| 01/04/1994 | US5276182 Process for preparing polyurea oligomers |
| 01/04/1994 | US5276169 Antimycotic carbonyl- and amino-substituted tetrahydrofurans |
| 01/04/1994 | US5276055 Antibiotic agents |
| 01/04/1994 | US5276024 3-substituted cephalosporins, and their use as medicaments |
| 01/04/1994 | US5276020 Anti-virals |
| 01/04/1994 | US5276019 Inhibitors for replication of retroviruses and for the expression of oncogene products |
| 01/04/1994 | US5276018 Composition comprising amino acids and methods for decreasing muscle breakdown |
| 01/04/1994 | US5275824 Therapeutic compositions with controlled release of medicaments supported on crosslinked polymers and coated with polymer films, and their preparation process |
| 01/04/1994 | US5275816 Cephalosporin derivatives |
| 01/03/1994 | CA2099630A1 Heterocyclyl-phenoxyalkyl-piperidinylpyridazines as antiviral agents |
| 01/03/1994 | CA2098241A1 Tetrazolyl-(phenoxy and phenoxyalkyl)-piperidinylpyridazines as antiviral agents |
| 01/02/1994 | CA2099712A1 Carbocyclic nucleosides containing bicyclic rings, oligonucleotides therefrom, process for their preparation, their use and intermediates |
| 12/29/1993 | EP0576230A1 2'-deoxy-2', 2'-difluoro(4-substituted pyrimidine) nucleosides having antiviral and anti-cancer activity and intermediates |
| 12/29/1993 | EP0576227A2 2'-Deoxy-2',2'-difluoro(2,6,8-substituted) purine nucleosides having anti-viral and anti-cancer activity and intermediates |
| 12/29/1993 | EP0576092A1 Recombinant Feline herpesvirus vaccine |
| 12/29/1993 | EP0575923A1 Triazole Derivatives |
| 12/29/1993 | EP0575614A1 Thiazole derivatives |
| 12/29/1993 | EP0575553A1 Recombinant hybrid porin epitopes |
| 12/29/1993 | EP0575544A1 Malaria recombinant poxvirus vaccine |
| 12/29/1993 | EP0575517A1 Lipid a analog/immunogenic carrier conjugates, the use thereof as vaccines and polyvalent hyperimmune gammaglobulins |
| 12/29/1993 | EP0575500A1 Hiv protease inhibitors |
| 12/29/1993 | EP0575491A1 Genetically engineered vaccine strain |
| 12/29/1993 | EP0575482A1 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
| 12/29/1993 | EP0575432A1 Modified proteins and their use for controlling viral infections |
| 12/29/1993 | EP0575425A1 USE OF OXAZOLO- 2,3-a]ISOINDOLE AND IMIDAZO 2,1-a]ISOINDOLE DERIVATIVES AS ANTIVIRAL DRUGS, AND NEW OXAZOLO 2,3-a]ISOINDOLE DERIVATIVES. |
| 12/29/1993 | EP0575375A1 Antibacterial condensed carbapenemes |
| 12/29/1993 | EP0575348A1 FLAGELLA-LESS $i(BORRELIA) |
| 12/29/1993 | CN1079964A Oxazolidinone antimicrobials containing substituted diazine moieties |
| 12/29/1993 | CN1079896A Topical aromatic releasing compositions |
| 12/29/1993 | CN1023295C Method and composition for prophylaxis and treatment of viral infections |
| 12/28/1993 | US5273984 Salts formed between basic histamine H2 -receptor antagonists and bismuth complexes |
| 12/28/1993 | US5273892 Culturing Pseudomonas |
| 12/28/1993 | CA1325638C Process for preparing azetidinones |
| 12/28/1993 | CA1325630C Lysocellin solids purification process |
| 12/28/1993 | CA1325594C Agents for the prophylaxis and therapy of retroviral infections |
| 12/25/1993 | CA2098222A1 Triazole derivatives |
| 12/23/1993 | WO1993025694A1 Inhibitors of ced-3 and related proteins |
| 12/23/1993 | WO1993025689A1 Cloning of gene encoding the gp28.5 protein of toxoplasma gondii; peptide fragments of said protein and their applications |
| 12/23/1993 | WO1993025682A2 Chimeric receptor polypeptides, human h13 proteins and uses thereof |
| 12/23/1993 | WO1993025673A1 In vivo gene therapy with intron-free sequence of interest |
| 12/23/1993 | WO1993025667A1 D-enzyme compositions and methods of their use |
| 12/23/1993 | WO1993025665A1 Recombinant herpesvirus of turkeys and uses thereof |
| 12/23/1993 | WO1993025582A1 A novel endothelial cell molecule mediating lymphocyte binding in man |
| 12/23/1993 | WO1993025575A1 Peptide for stimulation of cytotoxic t lymphocytes specific for hepatitis c virus |
| 12/23/1993 | WO1993025565A1 1,5-anhydrohexitol nucleoside analogues and pharmaceutical use thereof |
| 12/23/1993 | WO1993025557A1 Process for the preparation of clavulanic acid |
| 12/23/1993 | WO1993025551A1 3-substituted carbacephems |
| 12/23/1993 | WO1993025545A1 Novel quinoline derivatives and processes for preparing the same |
| 12/23/1993 | WO1993025543A2 Enniatines and enniatine derivates used to control endoparasites |
| 12/23/1993 | WO1993025210A1 Diphtheria toxin vaccines |
| 12/23/1993 | WO1993025200A1 Use of fatty acids, e.g. z-hydroxymystic acids, as antiviral agents |
| 12/23/1993 | CA2138415A1 1,5-anhydrohexitol nucleoside analogues and pharmaceutical use thereof |
| 12/23/1993 | CA2137930A1 Recombinant herpesvirus of turkeys and uses thereof |
| 12/23/1993 | CA2137681A1 Use of fatty acids, e.g.z-hydroxymystic acids, as antiviral agents |
| 12/23/1993 | CA2137679A1 Use of cyclic depsipeptides having 18 ring atoms for combating endoparasites, new cyclic depsipeptides having 18 ring atoms, and processes for their preparation |
| 12/23/1993 | CA2137547A1 Chimeric receptor polypeptides, human h13 proteins and uses thereof |
| 12/23/1993 | CA2117538A1 Process for the preparation of clavulanic acid |
| 12/23/1993 | CA2098876A1 2'-deoxy-2',2-'difluoro(2,6,8-substituted)purine nucleosides having anti-viral and anti-cancer activity and intermediates |
| 12/23/1993 | CA2098875A1 2'-deoxy-2'-2'-difluoro(4-substituted pyrimidine)nucleosides having anti-viral and anti-cancer activity and intermediates |
| 12/22/1993 | EP0575210A1 Azole derivatives, pharmaceutical compositions containing the same, and methods for treating mycosis and estrogen-dependent diseases |
| 12/22/1993 | EP0575097A1 2,3-Bis-carboxamidomethyl substituted oxiranes as inhibitors of HIV protease and their use for the treatment of AIDS |
| 12/22/1993 | EP0574857A1 Compounds 31668P and 31668U, a process for their production and their use |
| 12/22/1993 | EP0574781A2 2-Amino-5-heterocyclic-substituted-1,4-benzodiazepines and their use in the treatment of aids |
| 12/22/1993 | EP0574487A1 Use of 5-fluoro-2'-deoxy-3'-thiacytidine for the treatment of hepatitis b |
| 12/22/1993 | EP0574466A1 Expression of recombinant proteins in attenuated bacteria |
| 12/22/1993 | EP0574457A1 Antiviral nucleoside combination |
| 12/22/1993 | EP0574395A1 Cytokine immunoconjugates |
| 12/22/1993 | CN1079745A New 4-fluoro-7-oxo-H-pyridoi1,2,3-DEÙÛ1,4Ùbenzoxazing-6-carboxyl IC acids and esters |
| 12/22/1993 | CN1079743A Process for the production of clavulanic acid salts |
| 12/21/1993 | US5272266 Vinylsulphonylpristinamycin and its preparation |
| 12/21/1993 | US5272151 Aminoacyl and oligopeptidyl derivatives of allopurinol exhibiting immunostimulatory activity, and pharmaceutical formulations containing these substances |
| 12/21/1993 | CA1325424C Derivatives of tylosin and 10, 11, 12, 13- tetrahydrotylosin, methods of manufacture thereof and their use in pharmaceuticals and in the manufacture thereof |
| 12/20/1993 | CA2098448A1 Dna fragments which encode the transferrin receptor subunits of neisseria meningitidis |
| 12/20/1993 | CA2098165A1 Inhibitors of hiv protease useful for the treatment of aids |
| 12/17/1993 | CA2098063A1 Benzodiazepines |
| 12/16/1993 | DE4317458A1 Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung Use of cyclic depsipeptides having 18 ring atoms for the control of endoparasites, to novel cyclic depsipeptides having 18 ring atoms, and processes for their preparation |
| 12/15/1993 | EP0574231A1 Quinolone and naphthyridine derivatives having at the 3-position a group other than a carboxy group, as antibacterials |
| 12/15/1993 | EP0573616A1 RECOMBINANT FIV GLYCOPROTEIN 160 AND p24 GAG PROTEIN |
| 12/15/1993 | EP0573614A1 Attenuated, genetically-engineered pseudorabies virus s-prv-155 and uses thereof |
| 12/15/1993 | EP0573527A1 Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e. coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e. coli bacteria in humans |
| 12/15/1993 | EP0573479A1 Chimeric tar enzyme construction for hiv therapy |
| 12/15/1993 | CN1079472A Antimicrobial carbapenem derivatives, their preparation and their therapeutic use |
| 12/15/1993 | CN1079467A Azole compounds, their production and use |
| 12/14/1993 | US5270468 2- and 3- amino azido derivatives of 1,5-iminosugars |
| 12/14/1993 | US5270307 Pyrrolo(1,2-b)-(1,2)-benzothiazin-10-one and its use as an antimicrobial |
| 12/14/1993 | US5270182 Antibiotic compounds and their production |